Immediate Impact
2 from Science/Nature 57 standout
Citing Papers
Remibrutinib in Chronic Spontaneous Urticaria
2025 Standout
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Works of Kyle A. Beckwith being referenced
Ibrutinib treatment improves T cell number and function in CLL patients
2017 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Kyle A. Beckwith | 376 | 287 | 263 | 18 | 658 | |
| Lisa Bonello | 425 | 197 | 313 | 15 | 832 | |
| Rogier Mous | 170 | 296 | 239 | 35 | 698 | |
| Chingiz Underbayev | 384 | 326 | 225 | 18 | 656 | |
| Jack Reifert | 165 | 174 | 100 | 21 | 742 | |
| Nathan De Beule | 294 | 164 | 207 | 21 | 713 | |
| J.‐P. Magaud | 164 | 345 | 180 | 24 | 836 | |
| Rogier Kersseboom | 274 | 152 | 264 | 20 | 606 | |
| Justin C. Boysen | 386 | 247 | 348 | 24 | 665 | |
| Antonella Vallario | 291 | 156 | 382 | 17 | 844 | |
| Barry Turnbull | 438 | 363 | 259 | 18 | 754 |
All Works
Login with ORCID to disown or claim papers
Loading papers...